Simulations Plus Cash on Hand 2010-2024 | SLP
Simulations Plus cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Simulations Plus Annual Cash on Hand (Millions of US $) |
2024 |
$20 |
2023 |
$115 |
2022 |
$128 |
2021 |
$124 |
2020 |
$116 |
2019 |
$11 |
2018 |
$9 |
2017 |
$6 |
2016 |
$8 |
2015 |
$9 |
2014 |
$9 |
2013 |
$10 |
2012 |
$13 |
2011 |
$10 |
2010 |
$10 |
2009 |
$7 |
Simulations Plus Quarterly Cash on Hand (Millions of US $) |
2024-08-31 |
$20 |
2024-05-31 |
$119 |
2024-02-29 |
$109 |
2023-11-30 |
$114 |
2023-08-31 |
$115 |
2023-05-31 |
$122 |
2023-02-28 |
$115 |
2022-11-30 |
$132 |
2022-08-31 |
$128 |
2022-05-31 |
$122 |
2022-02-28 |
$125 |
2021-11-30 |
$124 |
2021-08-31 |
$124 |
2021-05-31 |
$120 |
2021-02-28 |
$118 |
2020-11-30 |
$119 |
2020-08-31 |
$116 |
2020-05-31 |
$7 |
2020-02-29 |
$12 |
2019-11-30 |
$13 |
2019-08-31 |
$11 |
2019-05-31 |
$10 |
2019-02-28 |
$10 |
2018-11-30 |
$9 |
2018-08-31 |
$9 |
2018-05-31 |
$7 |
2018-02-28 |
$7 |
2017-11-30 |
$7 |
2017-08-31 |
$6 |
2017-05-31 |
$8 |
2017-02-28 |
$7 |
2016-11-30 |
$9 |
2016-08-31 |
$8 |
2016-05-31 |
$7 |
2016-02-29 |
$7 |
2015-11-30 |
$7 |
2015-08-31 |
$9 |
2015-05-31 |
$6 |
2015-02-28 |
$6 |
2014-11-30 |
$6 |
2014-08-31 |
$9 |
2014-05-31 |
$8 |
2014-02-28 |
$10 |
2013-11-30 |
$11 |
2013-08-31 |
$10 |
2013-05-31 |
$10 |
2013-02-28 |
$10 |
2012-11-30 |
$11 |
2012-08-31 |
$13 |
2012-05-31 |
$13 |
2012-02-29 |
$13 |
2011-11-30 |
$13 |
2011-08-31 |
$10 |
2011-05-31 |
$10 |
2011-02-28 |
$9 |
2010-11-30 |
$9 |
2010-08-31 |
$10 |
2010-05-31 |
$9 |
2010-02-28 |
$9 |
2009-11-30 |
$8 |
2009-08-31 |
$7 |
2009-05-31 |
$7 |
2009-02-28 |
$8 |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Computer Software |
$0.554B |
$0.070B |
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|